Iluvien (Fluocinolone Acetonide Implant)

ILUVIEN is an FDA approved injectable intravitreal implant of fluocinolone acetonide and is the first diabetic macular edema (DME) treatment to deliver 36 months of continuous, low-dose corticosteroid with a single injection. Steroids may play an important role in addressing the inflammatory process associated with DME.

New Medication Available for Geographic Atrophy

Geographic atrophy is a vision-threatening condition that occurs during the late stages of dry AMD. Previously, no treatment options were available, but thanks to groundbreaking research, the FDA has approved the first and only treatment for geographic atrophy. Learn more about Syfovre™.